Having interstitial lung disease (ILD) is associated with a greater risk of lung cancer in scleroderma patients, according to…
José Lopes, PhD
José holds a PhD in neuroscience from the University of Porto, Portugal. After postdocs at Weill Connell Medicine and Western University, where he studied the processes driving hypertension and Alzheimer’s disease, he moved on in 2016 to a career in science writing and communication. José is the author of several peer-reviewed papers and a book chapter and has presented his research in numerous international meetings.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by José Lopes, PhD
Nailfold capillary damage was found to be a predictor of mortality in scleroderma patients, according to researchers from Australia.
Major healthcare organizations are throwing their support behind an initiative called “Let MI Doctors Decide” intended to improve patient access…
Throughout 2018, Scleroderma News provided daily coverage of treatment developments, clinical trials, risk factors, and non-pharmacological approaches related to scleroderma.
Innate Immune System and MicroRNA Play Crucial Roles in Scleroderma Development, Study Suggests
The innate immune system and small RNA molecules known as microRNA are key factors in the development of scleroderma, according…
Improving Adiponectin Protein Activity May Alleviate Skin Fibrosis in Scleroderma, Study Suggests
Restoring the activity of the protein adiponectin ameliorates skin fibrosis in mouse models of…
Skin levels of aquaporin 3 (AQP3), a protein which promotes skin hydration and wound healing, are reduced in the cells…